Applications
Human, mouse, rat and ‘bioprocess’ marker assays are available and the complete range may be viewed at: http://www.mesoscale.com/CatalogSystemWeb/WebRoot/products/assays.aspx
The assays cover the following applications:
- Clinical Immunology
- Disease-focused Biomarkers
- Cytokines and Chemokines
- High-Throughput Screening
- Metabolic
- Phosphoproteins, Intracellular Signaling, and Apoptosis
- Technology
- Ubiquitin
- Full listing of applications
In preclinical studies, assay of various cytokines that indicate hepatic and kidney toxicity are popular and using the MSD assay platform these can be ‘multiplexed’ i.e. up to 10 biomarkers can be measured simultaneously using as little as 25µL of plasma. In addition, the MSD assay platform can also be applied to clinical R&D.
As with preclinical studies, there are assays available to evaluate a drug’s toxicity in humans plus assays to support R&D into a range of therapeutic areas such as metabolic syndrome, inflammation, Alzheimer’s Disease, oncology and many more.